Arcus Biosciences Inc (RCUS)
16.71
+0.25
(+1.52%)
USD |
NYSE |
Nov 08, 10:34
Arcus Biosciences Revenue (Annual): 117.00M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 117.00M |
| December 31, 2022 | 112.00M |
| December 31, 2021 | 383.00M |
| December 31, 2020 | 78.00M |
| Date | Value |
|---|---|
| December 31, 2019 | 15.00M |
| December 31, 2018 | 8.353M |
| December 31, 2017 | 1.413M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
15.00M
Minimum
2019
383.00M
Maximum
2021
141.00M
Average
112.00M
Median
2022
Revenue (Annual) Benchmarks
| Merck & Co Inc | 60.12B |
| Intra-Cellular Therapies Inc | 462.18M |
| Syndax Pharmaceuticals Inc | -- |
| Clearside Biomedical Inc | 8.226M |
| Janux Therapeutics Inc | 8.083M |